Case Reports
doi: 10.1006/mgme.1999.2876.
Mutations of CTNS causing intermediate cystinosis
Affiliations
- PMID: 10444339
- DOI: 10.1006/mgme.1999.2876
Item in Clipboard
Case Reports
Mutations of CTNS causing intermediate cystinosis
Mol Genet Metab.
1999 Aug.
Abstract
Six patients with the intermediate form of cystinosis are described. Two have new mutations not previously described. The disease occurs due either to the combination of one mild mutation and one which is known to cause nephropathic cystinosis or to homozygosity for a predicted mild mutation. Partial phenotypic correction of cystinotic fibroblasts by transfection with normal cDNA or a cDNA derived from a mutation causing intermediate cystinosis is demonstrated.
Copyright 1999 Academic Press.
Similar articles
-
CTNS mutations in patients with cystinosis.Hum Mutat. 1999;14(6):454-8. doi: 10.1002/(SICI)1098-1004(199912)14:6<454::AID-HUMU2>3.0.CO;2-H. Hum Mutat. 1999. PMID: 10571941 Review.
-
Expression of CTNS alleles: subcellular localization and aminoglycoside correction in vitro.Mol Genet Metab. 2002 Feb;75(2):128-33. doi: 10.1006/mgme.2001.3272. Mol Genet Metab. 2002. PMID: 11855931
-
Analysis of the CTNS gene in patients of German and Swiss origin with nephropathic cystinosis.Hum Mutat. 2002 Sep;20(3):237. doi: 10.1002/humu.9063. Hum Mutat. 2002. PMID: 12204010
-
Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis.Hum Mutat. 2002 Dec;20(6):439-46. doi: 10.1002/humu.10141. Hum Mutat. 2002. PMID: 12442267
-
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.Mol Genet Metab. 2000 Sep-Oct;71(1-2):100-20. doi: 10.1006/mgme.2000.3062. Mol Genet Metab. 2000. PMID: 11001803 Review.
Cited by
-
Case Report: Cystinosis in a Chinese Child With a Novel CTNS Pathogenic Variant.Front Pediatr. 2022 Apr 15;10:860990. doi: 10.3389/fped.2022.860990. eCollection 2022. Front Pediatr. 2022. PMID: 35498770 Free PMC article.
-
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.EMBO J. 2001 Nov 1;20(21):5940-9. doi: 10.1093/emboj/20.21.5940. EMBO J. 2001. PMID: 11689434 Free PMC article.
-
First report of CTNS mutations in a Chinese family with infantile cystinosis.ScientificWorldJournal. 2015;2015:309410. doi: 10.1155/2015/309410. Epub 2015 Mar 17. ScientificWorldJournal. 2015. PMID: 25866837 Free PMC article.
-
Cystinosis: the evolution of a treatable disease.Pediatr Nephrol. 2013 Jan;28(1):51-9. doi: 10.1007/s00467-012-2242-5. Epub 2012 Aug 18. Pediatr Nephrol. 2013. PMID: 22903658 Free PMC article. Review.
-
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.Pharmacol Res Perspect. 2021 Apr;9(2):e00739. doi: 10.1002/prp2.739. Pharmacol Res Perspect. 2021. PMID: 33764642 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
